The Characterization of Small Bowel and Colonic Involvement in Patients With Seronegative Spondyloarthritides (SPONDILENDO)

Carol Davila University of Medicine and Pharmacy

Status: Completed

Conditions: Spondyloarthropathies

Treatments: Procedure: Capsule endoscopy examination; Procedure: Colonoscopy

Study type: Observational

Funder types: Other

Identifiers

NCT00768950

Idei-320/01-10-2007

UMFCD-Idei-320/2007

Details and patient eligibility

About

Up to 60% of patients with Seronegative Spondyloarthritides have inflammation in the colon or ileum. This is usually asymptomatic, but in 5 to 10% of patients with SA, Frank IBD will develop. Lesions of the bowel could also be present in the SA patients because of the potential injury posed by the NSAIDS, a common used medication in this setting.

It is the bowel involvement in patients with SA that we propose to characterize, partly because there are scant communicated data in the medical literature, especially regarding small bowel lesions.

Full description

The Seronegative Spondyloarthritides (SA) are a group of disorders that share certain clinical features and an association with the hla-b27 allele, having also overlapping features with inflammatory bowel disease (IBD).

Up to 60% of patients have inflammation in the colon or ileum. This is usually asymptomatic, but in 5 to 10% of patients with SA, Frank IBD will develop.

Lesions of the bowel could also be present in the SA patients because of the potential injury posed by the NSAIDS, a common used medication in this setting.

On the other hand, biologics used to treat patients with SA are believed to favorably influence the small bowel lesions that are concomitantly present.

It is the bowel involvement in patients with SA that we propose to characterize, partly because there are scant communicated data in the medical literature.

The design of the proposed study involves performing one full colonoscopic examination (including ileoscopy) followed by one capsule endoscopy examination to the patients with SA. Prior to these examination, the patency of the gi tract will be tested using a patency capsule. If the patency of the gi tract is not confirmed, then the capsule endoscopy examination is abandoned.

Our aim is to explore about 100 patients in three years, thus having a close-to-reality "look" into the presence and extent of bowel involvement in the pool of the patients having SA; and also to characterize the lesions mainly depending on the treatment received, concomitant pathology and the form of the disease. We also aim to identify a relationship between the lesions found at colonoscopy and capsule endoscopy, the purpose being the possibility to predict one having only performed the other.

Thus, we hope to identify the therapeutic strategies that are most suited in the management of these patients.

Enrollment: 65 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• signing of the inform consent
• subjects 18 years old or more
• patients with spondyloarthropathy as defined by the Amor criteria

Exclusion criteria

• presumed intestinal obstruction
• impaired deglutition
• cardiac pace-makers present
• pregnancy
• pelvic or abdominal radiotherapy anytime in the past
• major abdominal surgery anytime in the past
• major comorbidities which could represent a contraindication to a surgical abdominal intervention

Trial design

65 participants in 1 patient group

Spondyloarthropathies

Description:

Patients with spondyloarthropathies (ankylosing spondylitis, reactive arthritis, psoriatic arthritis and spondylitis, enteropathic arthritis and spondylitis, juvenile-onset spondyloarthritis, and undifferentiated spondyloarthritis) as defined by the AMOR criteria

Treatment:

Procedure: Colonoscopy

Procedure: Capsule endoscopy examination